Subscribe to RSS - FDA


Invacare auditor submits third report


ELYRIA, Ohio – Invacare’s independent auditor this week issued its certification report for the third phase of the consent decree indicating substantial compliance to the FDA’s quality system regulation.

Invacare receives feedback from FDA


ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Plaintiff reaches proposed settlement with Invacare


NEW YORK – The lead plaintiff in a class action lawsuit against Invacare has reached a proposed settlement of $11 million in cash, according to a statement from lead counsel Bernstein Litowitz Berger & Grossman.

Invacare puts ‘turnaround plan’ in motion


ELYRIA, Ohio – With a consent decree with the U.S. Food and Drug Administration (FDA) taking longer than it expected to resolve, Invacare has accelerated efforts to reduce its cost structure by reducing its workforce by 190 employees.

Snug Seat looks to get back in saddle

Company has lost market share since FDA began detaining certain products

MATTHEWS, N.C. – Snug Seat could soon resume distributing in the United States more than a dozen products manufactured in Denmark by R82.

In brief: Drive Medical buys in Europe, The Compliance Team expands service


PORT WASHINGTON, N.Y. – Drive Medical has acquired Dupont Medical, a manufacturer and distributor of healthcare products in France. Based in Frouard, Dupont manufactures and distributes everything from wheelchairs to homecare beds to patient lifts.

Invacare’s sales slump continues


ELYRIA, Ohio – Invacare ended the year the same way it started—hamstrung by a consent decree with the U.S. Food and Drug Administration (FDA) that has limited manufacturing at its Taylor Street facility.

Invacare amends credit agreement


ELYRIA, Ohio – Invacare has amended its credit agreement, giving the company more flexibility on its maximum leverage ratio financial covenant through Sept. 30, 2014, according to an announcement.

Update: Third-party auditor delays Invacare’s progress

Company expects re-audit in February

ELYRIA, Ohio – Invacare has more work to do before it submits a final audit to the U.S. Food and Drug Administration (FDA) for approval.

Sale boosts Invacare's earnings

Company prepares for life post-consent decree

ELYRIA, Ohio – The sale of Champion Manufacturing, a medical recliner business for dialysis clinics, provided a much-needed shot in the arm to Invacare’s third quarter earnings.